PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 148 filers reported holding PDL BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $125,000 | -52.1% | 39,955 | -43.0% | 0.00% | -100.0% |
| Q1 2019 | $261,000 | +139.4% | 70,125 | +86.3% | 0.00% | – |
| Q4 2018 | $109,000 | – | 37,651 | +55269.1% | 0.00% | – |
| Q1 2018 | $0 | – | 68 | -13.9% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 79 | -99.7% | 0.00% | – |
| Q3 2017 | $78,000 | +7700.0% | 23,165 | +5633.9% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 404 | +0.2% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 403 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 403 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | -50.0% | 403 | -29.5% | 0.00% | – |
| Q2 2016 | $2,000 | +100.0% | 572 | +45.2% | 0.00% | – |
| Q1 2016 | $1,000 | – | 394 | +629.6% | 0.00% | – |
| Q4 2015 | $0 | – | 54 | -34.9% | 0.00% | – |
| Q3 2015 | $0 | – | 83 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 83 | -41.1% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 141 | -99.6% | 0.00% | -100.0% |
| Q4 2014 | $241,000 | – | 31,358 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KESTREL INVESTMENT MANAGEMENT CORP | 1,634,000 | $4,804,000 | 1.81% |
| SMH CAPITAL ADVISORS INC | 80,722 | $237,000 | 0.37% |
| Matarin Capital Management, LLC | 1,126,641 | $3,312,325,000 | 0.25% |
| Hillsdale Investment Management Inc. | 337,800 | $993,000 | 0.14% |
| Zebra Capital Management LLC | 115,431 | $339,000 | 0.12% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,789,702 | $14,082,000 | 0.08% |
| Fortis Advisors, LLC | 45,602 | $134,000 | 0.07% |
| Municipal Employees' Retirement System of Michigan | 500,080 | $1,470,000 | 0.07% |
| RBF Capital, LLC | 173,090 | $508,000 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 392,276 | $1,153,000 | 0.06% |